LighthouseAI secures seed round of $2.25M for compliance product

The funds, the company says, will be used to fuel the growth and development of the flagship LighthouseAI product suite.

LighthouseAI, promotes itself as an industry leader in compliance solutions for the pharmaceutical supply chain with more than seven years of experience and more than 650 clients already engaged.

The category-defining product suite is engineered to automate pharmaceutical supply chain compliance for professionals who are responsible for compliance with federal and state regulations.

“With this investment, we’re enhancing our technology offerings and shaping the future of pharmaceutical compliance,” said Sumeet Singh, CEO of LighthouseAI.

“Our momentum is strong, leveraging our seven years of thought leadership in this space with new clients adopting our technology and current clients transitioning to our latest solutions.”

LighthouseAI says the regulation of the pharmaceutical supply chain has expanded extensively over the past decades as fallout from counterfeit schemes, tragedies resulting from poor compounding practices, the opioid epidemic, drug pricing expansion, drug shortages and more have brought extensive public and political scrutiny.

In its research, the company found pharmaceutical supply chain professionals grapple with critical and ever-evolving challenges in maintaining regulatory compliance. The product suite, it says, rooted in the rapidly growing RegTech space, is specifically designed to overcome these hurdles to reduce risk and cost associated with compliance.

Source link

Leave A Reply

Your email address will not be published.